Because the increased metabolic dysfunctions that occur during menopause coincide with changes in the levels of reproductive hormones, it is hypothesized that FSH may also be involved in these metabolic dysfunctions in postmenopausal women.[10] Although several studies have investigated the correlation between FSH level and MetS, lipid metabolism, dyslipidemia, and diabetes mellitus (DM) in postmenopausal women, the precise role of FSH in these metabolic dysfunctions in postmenopausal women is still poorly understood.[8,9,11,12]. Here, BRD2 is linked to metabolic syndrome.